• Text Resize A A A
  • Print Print
  • Share Share Share Share

Most or Moderately Effective Contraceptive Methods

Measure

The percentage of women aged 15-44 years at risk of unintended pregnancy that is provided a most effective (i.e., sterilization, contraceptive implants, intrauterine devices or systems (IUD/IUS)) or moderately effective (i.e., injectables, oral pills, patch, ring, or diaphragm) method of contraception.

Effectiveness of Family planning methods

text-only version

Addressing Limitations of Claims Data

Claims data do not capture several aspects of women’s risk of unintended pregnancy:  sexual experience, pregnancy intention, sterilization, or LARC insertion in a year preceding the measurement year, and infecundity for non-contraceptive reasons (unless the woman had a procedure during the measurement year).  These limitations can be partially addressed by using data from the National Survey of Family Growth (NSFG) to help interpret the performance measure rates for provision of most and moderately effective methods of contraception.

Learn more about interpreting rates for the contraceptive care measures. (203 KB)

How the Measure Should be Used


This measure is an intermediate outcome measure because it represents a decision that is made at the end of a clinical encounter about the type of contraceptive method a woman or teen will use, and because of the strong association between type of contraceptive method used and risk of unintended pregnancy. 

No specific benchmark has been set for this measure, but the Office of Population Affairs (OPA) does not expect it to reach 100%, as some women will make informed decisions to choose methods in the lower tier of efficacy even when offered the full range of methods and all logistical or financial barriers to access are removed.

Measure specifications and SAS code have been developed to calculate the measures using administrative claims data:

Content is undergoing 508 review and will be updated pending remediation. For immediate assistance, please contact: opa@hhs.gov.

Content created by Office of Population Affairs
Content last reviewed on January 18, 2019